Cargando…
Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44
BACKGROUND: Serglycin (SRGN), previously recognized as an intracellular proteoglycan involved in the storage processes of secretory granules, has recently been shown to be upregulated in several solid tumors. We have previously shown that SRGN in non-small cell lung cancer (NSCLC) promotes malignant...
Autores principales: | Guo, Jing-You, Chiu, Chu-Hsuan, Wang, Mei-Jung, Li, Fu-An, Chen, Jeou-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939340/ https://www.ncbi.nlm.nih.gov/pubmed/31898491 http://dx.doi.org/10.1186/s12929-019-0600-3 |
Ejemplares similares
-
Serglycin proteoglycans limit enteropathy in Trichinella spiralis-infected mice
por: Roy, Ananya, et al.
Publicado: (2016) -
Glycosaminoglycans and Proteoglycans
por: Pomin, Vitor H., et al.
Publicado: (2018) -
Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner
por: Guo, J-Y, et al.
Publicado: (2017) -
Glucocorticoid Effects on Proteoglycans and Glycosaminoglycans
por: Strokotova, Anastasia V., et al.
Publicado: (2022) -
Proteoglycans and Glycosaminoglycans in Stem Cell Homeostasis and Bone Tissue Regeneration
por: Chen, Jiawen, et al.
Publicado: (2021)